Page 19 - Robert Kramer News Today

State Roundup: U.S. Rep. Raskin spars with Emergent CEO over contaminated vaccines The State House lobby has been closed to visitors during the pandemic but reopens Friday. Governors Office photo RASKIN SPARS WITH EMERGENT CHIEF IN CONTENTIOUS HEARING: U.S. Rep. Jamie Raskin (D-Md.) sparred with the president and CEO of the Gaithersburg-based biotech company Emergent BioSolutions at a congressional hearing on Wednesday over decisions the company made both before and after it was forced to destr...

House Panel Details Baltimore Vaccine Plant Problems By Ralph Ellis May 20, 2021 -- Emergent BioSolutions was warned repeatedly of problems at the Baltimore factory where 15 million doses of the Johnson & Johnson COVID-19 vaccine were contaminated, documents released Wednesday by the House Select Subcommittee on the Coronavirus Crisis showed. “These warnings came in internal inspections as well as inspections and audits by FDA, Johnson & Johnson, and AstraZeneca,” the report said. �...

Pressure to reform and rebuild the nation’s emergency medical supply stockpile is mounting after shortages early in the coronavirus pandemic.

By The Associated Press BRUSSELS — The head of the World Trade Organization says it’s paramount to diversify vaccine manufacturing and develop production in Africa and Latin America to contain the coronavirus pandemic. On the eve of a global health summit in Rome, WTO Director-General Ngozi Okonjo-Iweala told European Union legislators on Thursday that normal market forces for exports and imports can’t apply when it comes to the life-or-death issue of COVID-19 vaccine...

Angry U.S. House Democrats on Wednesday had one key question as they grilled executives of a Maryland biotech manufacturer forced to dump 15 million doses of Johnson & Johnson’s COVID-19 vaccine.

Troubled Vaccine Maker and Its Founder Gave $2 Million in Political Donations Emergent BioSolutions faces scrutiny in Congress for ruining Covid-19 vaccines and securing lucrative federal contracts. Executives will appear before some lawmakers who benefited from the company’s spending. Fuad El-Hibri, third from left, the founder and executive chairman of Emergent BioSolutions, shaking hands with Robert Ehrlich, then the governor of Maryland, at an Emergent site in Frederick, Md., in 2004.Cred...

Emergent BioSolutions, the troubled vaccine maker whose Baltimore factory ruined millions of COVID-19 vaccine doses, has been paid more than $200 million in taxpayer money despite failing to address serious manufacturing control issues, according to documents released Wednesday by House Democrats.Democrats on the Oversight and Reform Select Subcommittee on the Coronavirus Crisis found that under a May 2020 contract issued by the Trump...

HEALTH-CORONAVIRUS/EMERGENT (UPDATE 3, PIX):UPDATE 3-Emergent may be able to resume J&J COVID-19 shot production within days -CEO

The government has so far paid Emergent BioSolutions $271 million, even though American regulators have yet to clear a single dose of vaccine produced at its manufacturing plant in Baltimore.

Emergent BioSolutions faces questions from lawmakers in vaccine probe Emergent BioSolutions executives testify on Capitol Hill Replay Video UP NEXT The beleaguered biotech firm Emergent BioSolutions will face a congressional inquiry Wednesday, scrutinized for what investigators say are the "serious deficiencies" in their manufacturing that led to up to 15 million doses worth of COVID-19 vaccine ingredients being compromised and disposed of because of cross-contamination. Top Emergent execut...